Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

OBJECTIVES: The aim of the study was to evaluate the cost-effectiveness (CE) of treatment with eplerenone versus standard care in adult patients with New York Heart Association class II chronic heart failure and reduced left ventricular ejection fraction from the perspective of the Greek national he...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clinicoecon Outcomes Res
Auteurs principaux: Athanasakis, Kostas, Bilitou, Aikaterini, Lee, Dawn, Karampli, Eleftheria, Karavidas, Apostolos, Parissis, John, Sykara, Georgia, Kyriopoulos, John
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2016
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5066703/
https://ncbi.nlm.nih.gov/pubmed/27785081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S107831
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires